A2M should not ignore the mass growing market of aging population in China and Asia, early entry position is the key. A2M already have distribution outlets in China and Korea. Can consider package as grandparents and babies deals. Those online sale platform many purchasers of IF products are now affluent grandparents who will spend to get the best products for their families. Many grandparents in their 50's 60's now will face bone and joints health concerns. I personally suffered from Osteoarithis from ignoring low vitamin D in my early 50's, eventhough vitamin D is superly cheap in Aust compare to in Asia. Supplement costs in Australia and NZ are cheap to add to the adult milk power, the regulation cost also will be cheaper than Infant fomular. There is also growing diabetics population, we used to buy very expensive milk powder in Asia for mum who also had kidney dialysis in her 80's. There was no option for pure A2 product which would have easier for her tummy as many Asian have issue with normal A1 diary products.
A2M Price at posting:
$4.24 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)